期刊文献+

艾素联合奥沙利铂治疗晚期结直肠癌的临床研究

Combination of docetaxel and oxaliplatin in the treatment of advanced colorectal cancer
下载PDF
导出
摘要 为了观察艾素(多西他赛,DOC)联合奥沙利铂(L-OHP)治疗晚期结直肠癌的疗效和毒副反应,对34例晚期结直肠癌患者采用DOC联合L-OHP方案化疗,DOC75mg/m2,静脉滴入,d1;L-OHP130mg/m2,静脉滴入,d2;28d为1个周期,至少2个周期后评定疗效。结果示34例可评价疗效,其中完全缓解(CR)1例,部分缓解(PR)12例,总有效率(CR+PR)为38.2%。中位生存期12个月。毒副反应主要为骨髓抑制、周围神经炎和脱发。初步研究结果提示,DOC联合L-OHP方案治疗晚期结直肠癌,缓解率高,毒副反应可以耐受。 In order to evaluate the efficacy and toxicity of docetaxel(DOC) combined with oxaliplatin (L-OHP) in the treatment of patients with advanced colorectal cancer, thirty-four cases with advanced colorectal cancern were treated by DOC combined with L-OHP: DOC 75mg/m^2 , iv gtt, at Day 1; L-OHP 130 mg/m^2, iv gtt, at Day 2. Each cycle included 28 days. After continuous two cycles, 27 out of 34 cases could be evaluated, 1 obtained complete response (CR) and 12 partial re-sponse (PR) with a total response rate of 38.2o,%o. The median survival duration was 12 months. The major toxicities were myelosuppression, peripheral neuritis and alopecia. In conclusion, the regimen of DOC combined with L-OHP in the treatment of patients with advanced colorectal cancer produces high response rate and its toxicity is well tolerable.
出处 《中华肿瘤防治杂志》 CAS 2007年第15期1182-1183,共2页 Chinese Journal of Cancer Prevention and Treatment
关键词 结直肠肿瘤/药物疗法 药物疗法 联合 多西他赛 奥沙利铂 colorectal neoplasms/drug therapy drug therapy,combination docetaxel oxaliplatin
  • 相关文献

参考文献4

  • 1Roth A D,Maibach R,Fazio N,et al.5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma:a phase Ⅰ-Ⅱ trial[J].Ann Oncol,2004,15(5):759-764. 被引量:1
  • 2杨柳青,秦叔逵,施毅,钱军,陈映霞,王琳,何泽明.多西紫杉醇为主方案治疗复治的晚期上消化道癌的临床研究[J].肿瘤防治杂志,2005,12(23):1809-1811. 被引量:3
  • 3Thuss-Patience P C,Kretzschmar A,Reichardt P.Docetaxel in the treatment of gastric cancer[J].Future Oncol,2006,2(5):603-620. 被引量:1
  • 4Sawabu N.Recent advances in chemotherapy for digestive cancers with special references to gastric and colonic cancers[J].Nippon Shokakibyo Gakkai Zasshi,2003,100(6):645-652. 被引量:1

二级参考文献8

  • 1吴成利,秦叔逵.食管癌的化疗新进展[J].医师进修杂志(外科版),2005,28(4):6-8. 被引量:20
  • 2秦叔逵.胃癌的化疗进展[M].216-226.北京:中国肿瘤临床年鉴[C].,2003.. 被引量:3
  • 3Gligorov J,Lotz J P.Preclinical pharmacology of the taxanes:implications of the differences[J].Oncologist,2004,9 (Suppl 2):3-8. 被引量:1
  • 4Sulkes A,Smyth J,Sessa C,et al.DOCETAXEL (Taxotere) in advanced gastric cancer:results of a phase Ⅱ clinical trial[J].Br J Cancer,1994,70(2):183-184. 被引量:1
  • 5Di Cosimo S,Ferretti G,Fazio N,et al.Docetaxel in advanced gastric cancer--review of the main clinical trials[J].Acta Oncol,2003,42(7):693-700. 被引量:1
  • 6Muro K,Hamaguchi T,Ohtsu A,et al.A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer[J].Ann Oncol,2004,15(6):955-959. 被引量:1
  • 7Moiseyenko V M,Ajani J A,Tjulandin S A,et al.Final results of a randomized controlled phase III trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-fluorouracil (F) to CF in patients (pts) with metastatic gastric adenocarcinoma (MGC)[J].Proc Am Soc Clin Oncol,2005,24:Abstract 4002. 被引量:1
  • 8钱军,秦叔逵,陈映霞,邵志坚,龚新雷.紫杉醇为主方案治疗中晚期上消化道癌的临床研究[J].肿瘤防治研究,2003,30(2):149-150. 被引量:10

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部